Education
About Us
Working with TipRanks
Follow Us
RemeGen Co. Ltd. Class H (HK:9995)
:9995
9995 Stock Chart & Stats
HK$76.30
-HK$0.38(-3.04%)
At close: 4:00 PM EST
HK$76.30
-HK$0.38(-3.04%)
Day’s Range― - ―
52-Week RangeHK$11.52 - HK$126.60
Previous CloseN/A
Volume1.38M
Average Volume (3M)6.34M
Market Cap
HK$47.26B
Enterprise ValueHK$31.39B
Total Cash (Recent Filing)HK$1.28B
Total Debt (Recent Filing)HK$2.67B
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding208,581,240
10 Day Avg. Volume6,644,676
30 Day Avg. Volume6,343,592
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)3.66
Price to Sales (P/S)4.24
P/FCF Ratio-5.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$99.82Price Target Upside30.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RemeGen Co. Ltd. Class H News
9995 FAQ
What was RemeGen Co. Ltd. Class H’s price range in the past 12 months?
RemeGen Co. Ltd. Class H lowest stock price was HK$11.52 and its highest was HK$126.60 in the past 12 months.
What is RemeGen Co. Ltd. Class H’s market cap?
RemeGen Co. Ltd. Class H’s market cap is HK$47.26B.
When is RemeGen Co. Ltd. Class H’s upcoming earnings report date?
RemeGen Co. Ltd. Class H’s upcoming earnings report date is Apr 01, 2026 which is in 104 days.
How were RemeGen Co. Ltd. Class H’s earnings last quarter?
RemeGen Co. Ltd. Class H released its earnings results on Oct 30, 2025. The company reported -HK$0.199 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.199.
Is RemeGen Co. Ltd. Class H overvalued?
According to Wall Street analysts RemeGen Co. Ltd. Class H’s price is currently Undervalued.
Does RemeGen Co. Ltd. Class H pay dividends?
RemeGen Co. Ltd. Class H does not currently pay dividends.
What is RemeGen Co. Ltd. Class H’s EPS estimate?
RemeGen Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RemeGen Co. Ltd. Class H have?
RemeGen Co. Ltd. Class H has 208,581,240 shares outstanding.
What happened to RemeGen Co. Ltd. Class H’s price movement after its last earnings report?
RemeGen Co. Ltd. Class H reported an EPS of -HK$0.199 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.263%.
Which hedge fund is a major shareholder of RemeGen Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:9995
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
RemeGen Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
495.23%
12-Months-Change
Fundamentals
Return on Equity
-39.64%
Trailing 12-Months
Asset Growth
3.65%
Trailing 12-Months
Company Description
RemeGen Co. Ltd. Class H
RemeGen Co. Ltd. Class H (9995) is a biopharmaceutical company based in China that specializes in the research, development, manufacturing, and commercialization of innovative therapies for cancer and autoimmune diseases. The company focuses on biologics, particularly monoclonal antibodies and fusion proteins, and has a strong pipeline of products aimed at addressing unmet medical needs in oncology and immunology.
9995 Stock 12 Month Forecast
Average Price Target
HK$99.82
▲(30.83% Upside)
Technical Analysis
Genscript Biotech
―
Zai Lab Ltd
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Simcere Pharmaceutical Group Limited
―
Shanghai Henlius Biotech, Inc. Class H
―
Options Prices
Currently, No data available
---